Revmacentrum MUDr. Mostera s.r.o.

Revmacentrum MUDr. Mostera s.r.o. conducts research on immune‑mediated conditions, evaluating new therapies for psoriatic arthritis, rheumatoid arthritis, and related inflammatory disorders.

• Psoriatic arthritis treatment effectiveness
• Rheumatoid arthritis therapeutic assessment
• Giant cell arteritis and polymyalgia rheumatica investigations

The site’s focus on immune health aims to improve patient outcomes by testing innovative biologic agents and safety profiles.

Clinical studies at the Brno‑Zidenice facility explore joint and bone disorders, including osteoarthritis and knee structural changes, to enhance treatment options for patients with chronic musculoskeletal pain.

• Knee osteoarthritis structural and symptomatic evaluation
• Osteoarthritis disease‑modifying therapy research
• Assessment of novel agents for joint health

By investigating disease progression and therapeutic impact, the centre seeks to advance care for individuals with musculoskeletal ailments.

The research program includes studies on conditions that affect skin and connective tissues, particularly psoriatic arthritis and related psoriasis‑driven joint disease, to refine diagnostic tools and therapeutic strategies.

• Psoriasis‑associated arthritis clinical evaluation
• Connective tissue disease treatment innovation
• Safety and efficacy of emerging biologics

Efforts at Revmacentrum aim to translate scientific insights into better management of skin‑related inflammatory disorders.